Unusual 11 Mid-Day Movers 11/04: (INHX) (LEDS) (POWR) Higher; (CEDC) (RNN) (EXAM) Lower
Tweet
Share
E-mail
Get Alerts INHX Hot Sheet
Join SI Premium – FREE
Inhibitex, Inc. (Nasdaq: INHX) 128.0% HIGHER; reported Q3 EPS of ($0.07), 2 cents better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $650,000.
Central European Distribution (Nasdaq: CEDC) 36.1% LOWER; reported Q3 EPS of $0.06, 14 cents worse than the analyst estimate of $0.20. Revenue for the quarter came in at $228.9 million versus the consensus estimate of $230.82 million. Central European Distribution sees FY11 EPS of $0.25 to $0.45, versus prior guidance of $0.80 to $1.00 and the consensus of $0.60. The company also sees FY11 revenue of $850 to $950 million, versus prior guidance of $900 million to $1.05 billion.
Rexahn Pharmaceuticals, Inc. (NYSE: RNN) 35.3% LOWER; today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder. The randomized, double-blind, placebo-controlled study compared two doses of Serdaxin, 0.5 mg and 5 mg, to placebo over an 8-week treatment period. Results from the study did not demonstrate Serdaxin’s efficacy compared to placebo measured by the Montgomery-Asberg Depression Rating Scale (MADRS). All groups showed an approximate -14 point improvement in the protocol defined primary endpoint of MADRS. All groups had a substantial number of patients who demonstrated a meaningful clinical improvement from baseline. The study showed Serdaxin to be safe and well tolerated.
SemiLEDs (Nasdaq: LEDS) 33.1% HIGHER; LED sector is hot today following news out of the China regulators are planning to phase out incandescent light bulbs.
PowerSecure International (Nasdaq: POWR) 28.8% HIGHER; reported Q3 EPS of $0.05, 11 cents better than the analyst estimate of ($0.06). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $30.51 million. PowerSecure also authorized a new $5 million common stock repurchase program.
ExamWorks (Nasdaq: EXAM) 27.8% LOWER; reports Q3 EPS of $0.00, 2 cents better than the analyst estimate of ($0.02). Revenue for the quarter came in at $119 million, versus the consensus estimate of $115.6 million. Sees FY11 sales $390 to $395 million, vs. the consensus of $409.6 million.
Alon USA Energy, Inc. (NYSE: ALJ) 27.3% HIGHER; reported Q3 EPS of $0.70, 21 cents better than the analyst estimate of $0.49. Revenue for the quarter came in at $2.06 billion versus the consensus estimate of $1.93 billion.
Rosetta Stone (NYSE: RST) 21.2% LOWER; reported Q3 EPS of ($0.06), $0.07 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $64.2 million versus the consensus estimate of $67.13 million. Sees Q4 2011 loss of ($0.43) - ($0.25), which may not compare to the consensus of $0.21. Sees Q4 2011 revenue of $64-$70 million, versus the consensus of $84.46 million.
DragonWave Inc. (Nasdaq: DRWI) 21.3% HIGHER; reported it plans to acquire Nokia Siemens Networks' (NYSE: NOK)(NYSE: SI) microwave transport business, including its associated operational support systems (OSS) and related support functions. Click here to see the full report.
MedAssets, Inc. (Nasdaq: MDAS) 21.0% HIGHER; reported Q3 EPS of $0.26, 9 cents better than the analyst estimate of $0.17. Revenue for the quarter came in at $143.6 million versus the consensus estimate of $137.61 million.
MasTec, Inc. (NYSE: MTZ) 20.1% LOWER; reported Q3 EPS of $0.36, in-line with the analyst estimate of $0.36. Revenue for the quarter came in at $865.3 million versus the consensus estimate of $776.28 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Central European Distribution (Nasdaq: CEDC) 36.1% LOWER; reported Q3 EPS of $0.06, 14 cents worse than the analyst estimate of $0.20. Revenue for the quarter came in at $228.9 million versus the consensus estimate of $230.82 million. Central European Distribution sees FY11 EPS of $0.25 to $0.45, versus prior guidance of $0.80 to $1.00 and the consensus of $0.60. The company also sees FY11 revenue of $850 to $950 million, versus prior guidance of $900 million to $1.05 billion.
Rexahn Pharmaceuticals, Inc. (NYSE: RNN) 35.3% LOWER; today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder. The randomized, double-blind, placebo-controlled study compared two doses of Serdaxin, 0.5 mg and 5 mg, to placebo over an 8-week treatment period. Results from the study did not demonstrate Serdaxin’s efficacy compared to placebo measured by the Montgomery-Asberg Depression Rating Scale (MADRS). All groups showed an approximate -14 point improvement in the protocol defined primary endpoint of MADRS. All groups had a substantial number of patients who demonstrated a meaningful clinical improvement from baseline. The study showed Serdaxin to be safe and well tolerated.
SemiLEDs (Nasdaq: LEDS) 33.1% HIGHER; LED sector is hot today following news out of the China regulators are planning to phase out incandescent light bulbs.
PowerSecure International (Nasdaq: POWR) 28.8% HIGHER; reported Q3 EPS of $0.05, 11 cents better than the analyst estimate of ($0.06). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $30.51 million. PowerSecure also authorized a new $5 million common stock repurchase program.
ExamWorks (Nasdaq: EXAM) 27.8% LOWER; reports Q3 EPS of $0.00, 2 cents better than the analyst estimate of ($0.02). Revenue for the quarter came in at $119 million, versus the consensus estimate of $115.6 million. Sees FY11 sales $390 to $395 million, vs. the consensus of $409.6 million.
Alon USA Energy, Inc. (NYSE: ALJ) 27.3% HIGHER; reported Q3 EPS of $0.70, 21 cents better than the analyst estimate of $0.49. Revenue for the quarter came in at $2.06 billion versus the consensus estimate of $1.93 billion.
Rosetta Stone (NYSE: RST) 21.2% LOWER; reported Q3 EPS of ($0.06), $0.07 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $64.2 million versus the consensus estimate of $67.13 million. Sees Q4 2011 loss of ($0.43) - ($0.25), which may not compare to the consensus of $0.21. Sees Q4 2011 revenue of $64-$70 million, versus the consensus of $84.46 million.
DragonWave Inc. (Nasdaq: DRWI) 21.3% HIGHER; reported it plans to acquire Nokia Siemens Networks' (NYSE: NOK)(NYSE: SI) microwave transport business, including its associated operational support systems (OSS) and related support functions. Click here to see the full report.
MedAssets, Inc. (Nasdaq: MDAS) 21.0% HIGHER; reported Q3 EPS of $0.26, 9 cents better than the analyst estimate of $0.17. Revenue for the quarter came in at $143.6 million versus the consensus estimate of $137.61 million.
MasTec, Inc. (NYSE: MTZ) 20.1% LOWER; reported Q3 EPS of $0.36, in-line with the analyst estimate of $0.36. Revenue for the quarter came in at $865.3 million versus the consensus estimate of $776.28 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley lists top 10 AI stocks to buy in Europe
- After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON
- Analyst names this stock the top beneficiary of AI power demand growth
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Unusual 11 Mid-Day Movers, Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
